Evaluation of the role of18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer
- 1 January 2008
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 47 (7) , 1229-1236
Abstract
As techniques for radiotherapy delivery have developed, increasingly accurate localisation of disease is demanded. Functional imaging, particularly PET and its fusion with anatomical modalities, such as PET/CT, promises to improve detection and characterisation of disease. This study evaluated the impact of (18)FDG-PET/CT on radiotherapy target volume definition in head and neck cancer (HNC). The PET/CT scans of patients with HNC were used in a radiotherapy planning (RTP) study. The gross tumour volume (GTV), clinical target volume (CTV) and planning target volume (PTV) were defined conventionally and compared to those defined using the PET/CT. Data were reported as the median value with 95% confidence intervals. Eighteen patients were consented, 9 had known primary tumour site, 9 presented as unknown primary. In nine cases where the primary site was known, the combined primary and nodal GTV (GTVp+n) increased by a median of 6.1cm(3) (2.6, 12.2) or 78% (18, 313), p=0.008 with CTV increasing by a median of 10.1cm(3) (1.3, 30.6) or 4% (0, 13) p=0.012. In 9 cases of unknown primary the GTVp+n increased by a median 6.3 cm(3) (0.2, 15.7) or 61% (4, 210), p=0.012, with CTV increasing by a median 155.4 cm(3) (2.7, 281.7) or 95% (1, 137), p=0.008. (18)FDG-PET revealed disease lying outside the conventional target volume, either extending a known area or highlighting a previously unknown area of disease, including the primary tumour in 5 cases. We recommend PET/CT in the RTP of all cases of unknown primary. In patients with a known primary, although the change in volume was statistically significant the clinical impact is less clear. (18)FDG-PET can also show areas within the conventional target volume that are hypermetabolic which may be possible biological target volumes for dose escalation studies in the future.Keywords
This publication has 21 references indexed in Scilit:
- Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imagingRadiotherapy and Oncology, 2005
- Head and Neck Malignancy: Is PET/CT More Accurate than PET or CT Alone?Radiology, 2005
- Dual Modality of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Patients with Cervical Carcinoma of Unknown PrimaryMedical Principles and Practice, 2005
- F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancerHead & Neck, 2005
- Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Co-registered FDG-PET/CT imaging for staging and IMRT treatment planning for squamous cell carcinoma of the head and neckInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Role of fusion in radiotherapy treatment planningSeminars in Nuclear Medicine, 2003
- Image fusion between 18 FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methodsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Metastatic Head and Neck Cancer: Role and Usefulness of FDG PET in Locating Occult Primary TumorsRadiology, 1999